SUPERNUS PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Rubin Jonathan | SVP, Chief Medical Officer | Tax Withholding | 821 | $35.59 | $29,219 | 6,595 | Dec 27, 2024 |
| Khattar Jack A. | President, CEO | Option Exercise | 14,000 | — | — | 960,245 | Dec 27, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 12,745 | $36.68 | $467,487 | 9,679 | Dec 3, 2024 |
| NEWHALL CHARLES W III | — | Sale | 10,700 | $36.24 | $387,768 | 130,275 | Nov 11, 2024 |
| Hudson Frederick M. | — | Sale | 8,722 | $36.28 | $316,434 | 28,395 | Nov 8, 2024 |
| GEMAYEL GEORGES | — | Sale | 10,787 | $36.30 | $391,568 | 13,315 | Nov 8, 2024 |
| Khattar Jack A. | President, CEO | Option Exercise | 125,000 | $9.13 | $1,141,250 | 1,051,172 | Nov 8, 2024 |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Sale | 15,000 | $36.98 | $554,700 | 8,200 | Nov 7, 2024 |
| GEMAYEL GEORGES | — | Sale | 14,213 | $36.62 | $520,480 | 13,315 | Nov 7, 2024 |
| Khattar Jack A. | President, CEO | Option Exercise | 125,000 | $9.13 | $1,141,250 | 1,051,172 | Nov 7, 2024 |
| GEMAYEL GEORGES | — | Sale | 10,000 | $31.33 | $313,300 | 13,315 | Sep 13, 2024 |
| Khattar Jack A. | President, CEO | Tax Withholding | 10,045 | $34.90 | $350,571 | 926,172 | Sep 3, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Option Exercise | 1,250 | — | — | 10,251 | Aug 20, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 14,491 | $35.31 | $511,677 | 8,570 | Mar 21, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Option Exercise | 400 | $25.30 | $10,120 | 8,970 | Mar 20, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Option Exercise | 12,364 | $25.30 | $312,809 | 20,934 | Mar 19, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 26,250 | $34.10 | $895,125 | 8,570 | Mar 13, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 3,884 | $32.99 | $128,133 | 8,570 | Mar 12, 2024 |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Tax Withholding | 460 | $27.94 | $12,852 | 7,779 | Feb 28, 2024 |
| Khattar Jack A. | President, CEO | Tax Withholding | 16,788 | $27.94 | $469,057 | 915,217 | Feb 28, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Option Exercise | 5,000 | $9.13 | $45,650 | 13,570 | Feb 26, 2024 |
| NEWHALL CHARLES W III | — | Award / Grant | 3,886 | — | — | 120,975 | Feb 23, 2024 |
| Barlow Carrolee | — | Award / Grant | 3,886 | — | — | 17,201 | Feb 23, 2024 |
| GEMAYEL GEORGES | — | Award / Grant | 3,886 | — | — | 17,201 | Feb 23, 2024 |
| Hudson Frederick M. | — | Award / Grant | 3,886 | — | — | 37,117 | Feb 23, 2024 |
| SIEBERT JOHN M | — | Award / Grant | 3,886 | — | — | 87,943 | Feb 23, 2024 |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Award / Grant | 1,875 | — | — | 8,186 | Feb 23, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Award / Grant | 1,250 | — | — | 9,208 | Feb 23, 2024 |
| DEC TIMOTHY C | Senior Vice-President & CFO | Award / Grant | 2,500 | — | — | 8,504 | Feb 23, 2024 |
| Rubin Jonathan | SVP, Chief Medical Officer | Award / Grant | 1,250 | — | — | 5,208 | Feb 23, 2024 |
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Tax Withholding | 485 | $29.06 | $14,094 | 86,933 | Feb 23, 2024 |
| Rubin Jonathan | SVP, Chief Medical Officer | Tax Withholding | 303 | $27.94 | $8,466 | 3,958 | Feb 22, 2024 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Award / Grant | 750 | — | — | 8,330 | Feb 22, 2024 |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Award / Grant | 750 | — | — | 6,646 | Feb 22, 2024 |
| DEC TIMOTHY C | Senior Vice-President & CFO | Award / Grant | 500 | — | — | 6,004 | Feb 22, 2024 |
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Award / Grant | 750 | — | — | 86,414 | Feb 22, 2024 |
| Khattar Jack A. | President, CEO | Other | 16,500 | — | — | 1,022,450 | Feb 12, 2024 |
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Option Exercise | 8,000 | $9.24 | $73,920 | 93,664 | Jan 10, 2024 |
| Rubin Jonathan | Sr. VP, Chief Medical Officer | Tax Withholding | 204 | $27.66 | $5,643 | 3,243 | Dec 22, 2023 |
| Khattar Jack A. | President, CEO | Option Exercise | 25,000 | — | — | 892,463 | Dec 22, 2023 |
| NEWHALL CHARLES W III | — | Sale | 2,500 | $28.01 | $70,025 | 117,089 | Nov 16, 2023 |
| Hudson Frederick M. | — | Option Exercise | 7,457 | $9.24 | $68,903 | 42,324 | Nov 15, 2023 |
| Mottola Frank | SVP, Quality, GMP, Ops, IT | Option Exercise | 2,000 | $9.24 | $18,480 | 6,791 | Nov 14, 2023 |
| DEC TIMOTHY C | Senior Vice-President & CFO | Tax Withholding | 1,911 | $26.91 | $51,425 | 5,089 | Oct 13, 2023 |
| Bhatt Padmanabh P. | Sr. VP of IP, CSO | Option Exercise | 2,500 | — | — | 8,347 | Sep 7, 2023 |
| Khattar Jack A. | President, CEO | Option Exercise | 35,000 | — | — | 884,267 | Sep 7, 2023 |
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Sale | 8,100 | $32.00 | $259,200 | 85,249 | Aug 30, 2023 |
| Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Sale | 5,135 | $31.59 | $162,215 | 85,249 | Aug 25, 2023 |
| DEC TIMOTHY C | Senior Vice-President & CFO | Tax Withholding | 709 | $36.47 | $25,857 | 2,650 | May 11, 2023 |
| Khattar Jack A. | President, CEO | Option Exercise | 31,250 | — | — | 864,272 | May 11, 2023 |